HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)

Jaap C. Reijneveld; Corneel Coens; Martin J. B. Taphoorn; Peter Sillevis Smitt; Paul M. Clement; Ahmed Idbaih; Filip de Vos; Martin Klein; Wolfgang Wick; Paul Mulholland; Joanne Lewis; Vassilis Golfinopoulos; Andrew Bottomley; Martin van den Bent

HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)

Jaap C. Reijneveld, Corneel Coens, Martin J. B. Taphoorn, Peter Sillevis Smitt, Paul M. Clement, Ahmed Idbaih, Filip de Vos, Martin Klein, Wolfgang Wick, Paul Mulholland, Joanne Lewis, Vassilis Golfinopoulos, Andrew Bottomley, Martin van den Bent

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	203-203
Journal	Neuro-oncology
Volume	19
Publication status	Published - Nov 2017

Cite this

Reijneveld, J. C., Coens, C., Taphoorn, M. J. B., Smitt, P. S., Clement, P. M., Idbaih, A., de Vos, F., Klein, M., Wick, W., Mulholland, P., Lewis, J., Golfinopoulos, V., Bottomley, A., & van den Bent, M. (2017). HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091). Neuro-oncology, 19, 203-203.

@article{f3bae6920a2840089c3974ee2cd573c8,

title = "HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)",

author = "Reijneveld, {Jaap C.} and Corneel Coens and Taphoorn, {Martin J. B.} and Smitt, {Peter Sillevis} and Clement, {Paul M.} and Ahmed Idbaih and {de Vos}, Filip and Martin Klein and Wolfgang Wick and Paul Mulholland and Joanne Lewis and Vassilis Golfinopoulos and Andrew Bottomley and {van den Bent}, Martin",

year = "2017",

month = nov,

language = "English",

volume = "19",

pages = "203--203",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

}

Reijneveld, JC, Coens, C, Taphoorn, MJB, Smitt, PS, Clement, PM, Idbaih, A, de Vos, F, Klein, M, Wick, W, Mulholland, P, Lewis, J, Golfinopoulos, V, Bottomley, A & van den Bent, M 2017, 'HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)', Neuro-oncology, vol. 19, pp. 203-203.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)

AU - Reijneveld, Jaap C.

AU - Coens, Corneel

AU - Taphoorn, Martin J. B.

AU - Smitt, Peter Sillevis

AU - Clement, Paul M.

AU - Idbaih, Ahmed

AU - de Vos, Filip

AU - Klein, Martin

AU - Wick, Wolfgang

AU - Mulholland, Paul

AU - Lewis, Joanne

AU - Golfinopoulos, Vassilis

AU - Bottomley, Andrew

AU - van den Bent, Martin

PY - 2017/11

Y1 - 2017/11

M3 - Meeting Abstract

SN - 1522-8517

VL - 19

SP - 203

EP - 203

JO - Neuro-oncology

JF - Neuro-oncology

ER -